## Background: Inherited risk factors have been suggested to play an important role in the pathogenesis of vascular complications of inflammatory bowel disease (ibd). the aim of the present study was to investigate the role of mutations associated with cardiovascular disease in ibd patients with or
Incidence and risk factors for gallstones in patients with inflammatory bowel disease: A large case-control study
β Scribed by Fabrizio Parente; Luca Pastore; Stefano Bargiggia; Claudia Cucino; Salvatore Greco; Mirko Molteni; Sandro Ardizzone; Gabriele Bianchi Porro; Gianluca M. Sampietro; Riccardo Giorgi; Roberto Moretti; Silvano Gallus
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 122 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
The risk for gallstones (GD) in inflammatory bowel diseases and the factors responsible for this complication have not been well established. We studied the incidence of GD in a cohort of Crohn's disease (CD) and ulcerative colitis (UC) patients and investigated the related risk factors. A case-controlled study was carried out. The study population included 634 inflammatory bowel disease (IBD) patients (429 CD, 205 UC) and 634 age-matched, sex-matched, and body mass index (BMI)-matched controls free of GD at enrollment, who were followed for a mean of 7.2 years (range, 5-11 years). The incidence of GD was calculated by dividing the number of events per person-years of follow-up. Multivariate analysis was used to discriminate among the impact of different variables on the risk of developing GD. The incidence rates of GD were 14.35/1,000 persons/year in CD as compared with 7.75 in matched controls (P=0.012) and 7.48/1000 persons/year in UC patients as compared with 6.06 in matched-controls (P=0.38). Ileo-colonic CD location (OR, 2.14), disease duration>15 years (OR, 4.26), >3 clinical recurrences (OR, 8.07), ileal resection>30 cm (OR, 7.03), >3 hospitalizations (OR, 20.7), multiple TPN treatments (OR, 8.07), and long hospital stay (OR, 24.8) were significantly related to GD in CD patients.
Conclusion:
Only cd patients have a significantly higher risk of developing gd than well-matched hospital controls. site of disease at diagnosis, lifetime surgery, extent of ileal resections, number of clinical recurrences, tpn, and the frequency and duration of hospitalizations are independently associated with gd.
π SIMILAR VOLUMES
Background: The use of complementary and alternative medicine in inflammatory bowel disease (IBD) has been extensively studied. However, the use of probiotics and prebiotics is poorly documented, despite evidence of efficacy of particular probiotic strains in specific forms of IBD. ## Methods: A
## Background: The role of narcotic use in patients with inflammatory bowel disease (IBD) is poorly defined. We sought to determine the clinical features of patients with IBD who use narcotics and factors associated with the discontinuation of narcotics. ## Methods: A centralized index was used
## Background: Inflammatory bowel diseases (ibds) are a result of interactions between luminal pathogens and the intestinal immune response. cyclooxygenase-2 (cox-2) plays a key role in the regulation of the inflammatory response upon stimulation by luminal pathogens via toll-like receptors. ## Me
## Abstract ## Objective Patients with systemic lupus erythematosus (SLE) are significantly more likely to experience a myocardial infarction or a stroke than ageβmatched controls. We compared the prevalence of conventional and lupusβspecific risk factors in patients with SLE just before a cardiov